Dr. Rachel Knox is passionate about cannabis. As an M.D. with formal training in family and integrative medicine, in addition to having an MBA,  she is also a cannabis specialist and the co-founder of the Canna MDs, with her sister Dr. Jessica Knox. Dr. Rachel Knox counsels over 500 patients per month in medical cannabis care and has witnessed cannabis play a significant role in helping patients gain control of, not only their health, but also obtain an overall sense of wellness in their lives.

As such, she is on a mission to destigmatize cannabis use as a safe, effective, and powerful way to heal. I recently chatted with Dr. Rachel to get her thoughts on what the rising federal administration’s views on cannabis mean for the industry. While she believes it’s too early to tell, there are a few concerns.

“It’s evident that medical cannabis and access remain on legislators minds as more states are adopting medical laws. But, in some states where adult (recreational) use has been legalized, we are seeing medical programs [getting] phased out,” she claims.

As “big pharma” positions itself to enter the industry as a major player, one that the federal government has a history of working with, stakeholders—such as patients, cultivators, manufacturers, dispensaries, and legislators—must take a step back and think about what this means for the industry and their respective interests.

Here’s more from our interview with Dr. Rachel Knox:

What are a few factors we should consider in 2017 on the medicinal front?

Dr. Knox: I wish I had a crystal ball to show me what will happen, but while I don’t, I do anticipate that big pharma will attempt to stake a claim in ownership over cannabis as medicine, as state-sanctioned recreational markets devalue the medicinal essence of cannabis. We are already seeing this happen in states like Washington, where the state has enacted allowable limits of common chemicals found in fertilizers, pesticides, and other cultivation products, and has, additionally, prohibited the use “medical cannabis” on all product labels.

So, what does that mean?

Dr. Knox: This means that cannabis and the products made from it are allowed to contain toxic chemicals—to an allowable degree—that, quite honestly, render them non-medicinal. As such, I advise my patients to use only organic, pure, whole plant cannabis and cannabis products that are 100% free of toxic chemicals. You cannot expect to heal from a product that has even trace amounts of toxic elements; this is counterproductive.

Yet, I also believe that the big industry players know this, as well. As recreational products become less medicinal, I do believe we will see big pharma stepping in, as the gatekeeper to cannabis “medicines.”

Is big pharma’s entrance into the market a bad thing?

Dr. Knox: I don’t know for certain, but what I do know for sure is that it’s an incredibly nuanced thing, with plenty of negative implications to match any good ones. However, if I had to choose just one area of concern with big pharma, it would be their lack of care in understanding and respecting natural, whole plant medicine, and the common person’s autonomy in using it.

I do not like how big pharma, the FDA, and big medicine distort, down-play, and discredit natural medicine. Cannabis has been rigorously tested and is considered significantly safer than tobacco and alcohol, and even less addictive than candy and caffeine! What is notable is that these products are all considered toxic, yet are free for public purchase and consumption. To the contrary, because cannabis heals, there has been a monumental struggle to make it mainstream, but not also without restrictive regulation. Where is the logic [in that]?

As a doctor, how do you balance being a proponent of medical cannabis and an opponent of big pharma?

Dr. Knox: I am absolutely a proponent of whole plant cannabis medicine and an opponent of big pharma’s control of it. This does not mean that I don’t advocate for standardization of processing and responsible oversight—I absolutely do, as should we all, because this is integral for mass adoption by patients and healthcare providers alike. I simply believe that people have a right to freely access and use—intentionally and safely—cultivated natural elements as medicine, and this includes cannabis.

This article originally appeared on BlackEnterprise.com.

Meet Jeannette Ward, former seven-year Coca Cola career climber who recently took the smart leap into the cannabis industry.

Ward serves as executive director (data and marketing) at MJ Freeway, the market leader in ‘seed to sell’ cannabis compliance software & professional consulting services.

Find out why Ward gave up Coke for cannabis, and what she plans to get in return.

How did you get involved in the cannabis industry?

Ward: I was working with Coca Cola in communications, marketing, and data management. I had a role where I had a little more time than usual so I had an interest in doing some consulting and sharpening my own skills around marketing and pushing the envelope with new technologies and new ways of approaching marketing that people weren’t quite ready for.

I took on consulting clients—one of those clients was MJ freeway.  I did that for a few months then they made me an offer to come on full-time. I decided it was a once in a lifetime opportunity.

I was probably not going to see another industry that was going to have the explosive growth that cannabis is going to have. I wanted the opportunity to shape a new industry.

Did you have interest in the industry prior to your career involvement?

Yes and no. I started consuming when I was young and then I stopped consuming because I definitely had the perception in my head that it was drugs, that I was getting high and that it wasn’t the best use of my time and resources.

I went about 18 years without consuming and I wasn’t at all involved in cannabis or the cannabis culture. When I took the job, my mindset was, ‘let adults do what adults want to do.’ Then, I got educated on the plant, and on the medicine, and on the best of what cannabis culture is—- activism and giving back, and building a better industry. I became a convert. This medicine will change the world.

Have you had any backlash given your career choice?

I have. I got asked to be off a board that I was on. I have some friends who no longer respond to me on Instagram or via email. People definitely have their beliefs, and they don’t have the education.

We have the wrong language around it. When you talk about it as getting high or stoners, people have this idea in their mind. Us activists have to do a better job with the language and the education.

Why do you believe there is a lack of color in cannabis?

I’m going to take off my MJ Freeway hat for a second and I’m going to put on my vice chair of the Minority Cannabis Business Association hat. Our point of view is that it’s 3 things:

1. It’s cost of entry. Let’s take Philadelphia, that’s just passed its law but is now developing its regulations. The law says if you’re going to apply for a license in Philadelphia, you have write a $200k check to apply, and you have to show $500k in liquid capital, and I believe its $2mill in assets. That kind of capital isn’t typically available to communities of color, especially communities impacted by the war on drugs.
2. There are laws that say if you have a prior cannabis conviction, you can’t own a business. Sometimes, they go so far as to say if you have a prior cannabis conviction you can’t even work in the industry—you can’t get a job as a budtender or cultivator.
3. Stigma. In the African American community there is a hard reaction to drugs to get as far away from them as you can to change the perception of who we are as a community.  There are stigmas and we have to educate people saying, 'It’s okay to do this and here’s how you do it very carefully to protect yourself.’

Now that you’ve entered this new industry, what is your ultimate goal in this space?

I want to do good.

What advice would you have for a young African American entrepreneur looking to enter the cannabis field?

1. Do your research. The industry is so young and was really born after the internet, so you can find most all information online.
2. Whatever you’re good at doing now, you can do it in cannabis, so consider that.
3. Find the competition. Figure out how you’re going to be different and how you’re going to be better.

Originally published on BlackEnterprise.com